Report Title | Price | Action |
---|---|---|
Blepharospasm (Ophthalmology) - Drugs in Development, 2021
Blepharospasm (Ophthalmology) - Drugs in Development, 2021 Summary Blepharospasm (Ophthalmology) - Drugs in Development, 2021 provides an overview o...
Published: Apr-2021 | No. of Pages: 30
|
$ 2000 | |
Sodium Channel Protein Type 9 Subunit Alpha (Neuroendocrine Sodium Channel or Peripheral Sodium Channel 1 or Voltage Gated Sodium Channel Subunit Alpha Nav1.7 or SCN9A) - Drugs in Development, 2021
Sodium Channel Protein Type 9 Subunit Alpha (Neuroendocrine Sodium Channel or Peripheral Sodium Channel 1 or Voltage Gated Sodium Channel Subunit Alph...
Published: Apr-2021 | No. of Pages: 115
|
$ 3000 | |
Apolipoprotein C III (APOC3) - Drugs in Development, 2021
Apolipoprotein C III (APOC3) - Drugs in Development, 2021 Summary Apolipoprotein C III (APOC3) - Drugs in Development, 2021 provides in depth analys...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
Eukaryotic Translation Initiation Factor 4E (eIF 4F 25 kDa Subunit or mRNA Cap Binding Protein or EIF4E) - Drugs in Development, 2021
Eukaryotic Translation Initiation Factor 4E (eIF 4F 25 kDa Subunit or mRNA Cap Binding Protein or EIF4E) - Drugs in Development, 2021 Summary Eukary...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
Fungal Keratitis (Ophthalmology) - Drugs in Development, 2021
Fungal Keratitis (Ophthalmology) - Drugs in Development, 2021 Summary Fungal Keratitis (Ophthalmology) - Drugs in Development, 2021 provides an over...
Published: Apr-2021 | No. of Pages: 30
|
$ 2000 | |
Sodium Dependent Dopamine Transporter (DA Transporter or DAT or Solute Carrier Family 6 Member 3 or SLC6A3) - Drugs in Development, 2021
Sodium Dependent Dopamine Transporter (DA Transporter or DAT or Solute Carrier Family 6 Member 3 or SLC6A3) - Drugs in Development, 2021 Summary Sod...
Published: Apr-2021 | No. of Pages: 115
|
$ 3000 | |
Aromatase (Estrogen Synthase or Cytochrome P 450AROM or Cytochrome P450 19A1 or CYP19A1 or EC 1.14.14.14) - Drugs in Development, 2021
Aromatase (Estrogen Synthase or Cytochrome P 450AROM or Cytochrome P450 19A1 or CYP19A1 or EC 1.14.14.14) - Drugs in Development, 2021 Summary Aroma...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
Apolipoprotein E (APOE) - Drugs in Development, 2021
Apolipoprotein E (APOE) - Drugs in Development, 2021 Summary Apolipoprotein E (APOE) - Drugs in Development, 2021 provides in depth analysis on Apol...
Published: Apr-2021 | No. of Pages: 45
|
$ 3000 | |
Limbal Stem Cell Deficiency (LSCD) (Ophthalmology) - Drugs in Development, 2021
Limbal Stem Cell Deficiency (LSCD) (Ophthalmology) - Drugs in Development, 2021 Summary Limbal Stem Cell Deficiency (LSCD) (Ophthalmology) - Drugs i...
Published: Apr-2021 | No. of Pages: 30
|
$ 2000 | |
Stimulator Of Interferon Genes Protein (Endoplasmic Reticulum Interferon Stimulator or Mediator Of IRF3 Activation or Transmembrane Protein 173 or STING or TMEM173) - Drugs in Development, 2021
Stimulator Of Interferon Genes Protein (Endoplasmic Reticulum Interferon Stimulator or Mediator Of IRF3 Activation or Transmembrane Protein 173 or STI...
Published: Apr-2021 | No. of Pages: 115
|
$ 3000 | |
Arylsulfatase A (Cerebroside Sulfatase or ASA or ARSA or EC 3.1.6.8) - Drugs in Development, 2021
Arylsulfatase A (Cerebroside Sulfatase or ASA or ARSA or EC 3.1.6.8) - Drugs in Development, 2021 Summary Arylsulfatase A (Cerebroside Sulfatase or ...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
Tumor Necrosis Factor Receptor Superfamily Member 10A (Death Receptor 4 or TNF Related Apoptosis Inducing Ligand Receptor 1 or TRAIL Receptor 1 or DR4 or CD261 or TNFRSF10A) - Drugs in Development, 2021
Tumor Necrosis Factor Receptor Superfamily Member 10A (Death Receptor 4 or TNF Related Apoptosis Inducing Ligand Receptor 1 or TRAIL Receptor 1 or DR4...
Published: Apr-2021 | No. of Pages: 45
|
$ 3000 | |
Brain (Head) Trauma (Other Diseases) - Drugs in Development, 2021
Brain (Head) Trauma (Other Diseases) - Drugs in Development, 2021 Summary Brain (Head) Trauma (Other Diseases) - Drugs in Development, 2021 provides...
Published: Apr-2021 | No. of Pages: 30
|
$ 2000 | |
5-Hydroxytryptamine Receptor 1A (5 HT1A or G 21 or Serotonin Receptor 1A or HTR1A) - Drugs in Development, 2021
5-Hydroxytryptamine Receptor 1A (5 HT1A or G 21 or Serotonin Receptor 1A or HTR1A) - Drugs in Development, 2021 Summary 5-Hydroxytryptamine Receptor...
Published: Apr-2021 | No. of Pages: 115
|
$ 3000 | |
Aspartoacylase (Aminoacylase 2 or ACY2 or ASPA or EC 3.5.1.15) - Drugs in Development, 2021
Aspartoacylase (Aminoacylase 2 or ACY2 or ASPA or EC 3.5.1.15) - Drugs in Development, 2021 Summary Aspartoacylase (Aminoacylase 2 or ACY2 or ASPA o...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
C-X-C Chemokine Receptor Type 4 (FB22 or Fusin or HM89 or LCR1 or Leukocyte Derived Seven Transmembrane Domain Receptor or Lipopolysaccharide Associated Protein 3 or Stromal Cell Derived Factor 1 Receptor or NPYRL or CD184 or CXCR4) - Drugs in Development, 2021
C-X-C Chemokine Receptor Type 4 (FB22 or Fusin or HM89 or LCR1 or Leukocyte Derived Seven Transmembrane Domain Receptor or Lipopolysaccharide Associat...
Published: Apr-2021 | No. of Pages: 65
|
$ 3000 | |
Acute Bronchitis (Respiratory) - Drugs in Development, 2021
Acute Bronchitis (Respiratory) - Drugs in Development, 2021 Summary Acute Bronchitis (Respiratory) - Drugs in Development, 2021 provides an overview...
Published: Apr-2021 | No. of Pages: 30
|
$ 2000 | |
Sodium Dependent Serotonin Transporter (5HT Transporter or 5HTT or Solute Carrier Family 6 Member 4 or SLC6A4) - Drugs in Development, 2021
Sodium Dependent Serotonin Transporter (5HT Transporter or 5HTT or Solute Carrier Family 6 Member 4 or SLC6A4) - Drugs in Development, 2021 Summary ...
Published: Apr-2021 | No. of Pages: 115
|
$ 3000 | |
B Lymphocyte Antigen CD19 (B Lymphocyte Surface Antigen B4 or Differentiation Antigen CD19 or T Cell Surface Antigen Leu 12 or CD19) - Drugs in Development, 2021
B Lymphocyte Antigen CD19 (B Lymphocyte Surface Antigen B4 or Differentiation Antigen CD19 or T Cell Surface Antigen Leu 12 or CD19) - Drugs in Develo...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
Atypical Chemokine Receptor 3 (C-X-C Chemokine Receptor Type 7 or Chemokine Orphan Receptor 1 or G Protein Coupled Receptor 159 or G Protein Coupled Receptor RDC1 Homolog or GPR159 or CXCR7 or ACKR3) - Drugs in Development, 2021
Atypical Chemokine Receptor 3 (C-X-C Chemokine Receptor Type 7 or Chemokine Orphan Receptor 1 or G Protein Coupled Receptor 159 or G Protein Coupled R...
Published: Apr-2021 | No. of Pages: 30
|
$ 3000 |